Funding · Company
Superluminal Medicines, Inc.
Boston, MABiotech & Pharma
Superluminal Medicines, Inc. of Boston, MA has disclosed $111M across 3 Form D offerings filed with the SEC between Aug 28, 2023 and Sep 3, 2026.
$111M
Total disclosed
3
Form D offerings
6
Open roles today
Hiring — 6 open roles as of Nov 6, 2026
Based in Boston, MA. Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$20M
Form D · Sep 4, 2024 ↗
Q3 2024
· target $120M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2023SEC CIK0001989478Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →